<?xml version='1.0' encoding='utf-8'?>
<record xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
			<header>
				<identifier>oai:bovine-ojs-tamu.tdl.org:article/8195</identifier>
				<datestamp>2021-08-31T19:00:07Z</datestamp>
				<setSpec>bovine:ART</setSpec>
			</header>
			<metadata>
<oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en">Efficacy of a combination modified-live IBR-BVD-PI3- BRSV vaccine + Mannheimia haemolytica toxoid against challenge with virulent bovine respiratory syncytial virus (BRSV) in young calves 60 days of age</dc:title>
	<dc:creator xml:lang="en">Masic, Aleksandar</dc:creator>
	<dc:creator xml:lang="en">Sobecki, Brian</dc:creator>
	<dc:creator xml:lang="en">Mahan, Suman</dc:creator>
	<dc:creator xml:lang="en">Brice, Chadwick</dc:creator>
	<dc:creator xml:lang="en">Mattern, Sally</dc:creator>
	<dc:creator xml:lang="en">Meinert, Todd</dc:creator>
	<dc:creator xml:lang="en">Correas, Ignacio</dc:creator>
	<dc:creator xml:lang="en">Moulin, VÃ©ronique</dc:creator>
	<dc:creator xml:lang="en">Ellis, John</dc:creator>
	<dc:subject xml:lang="en">BRSV</dc:subject>
	<dc:subject xml:lang="en">lung lesions</dc:subject>
	<dc:subject xml:lang="en">mortality</dc:subject>
	<dc:subject xml:lang="en">toxoid</dc:subject>
	<dc:subject xml:lang="en">5-way vaccine</dc:subject>
	<dc:description xml:lang="en">Efficacy of attenuated (att) bovine respiratory syncytial virus (attBRSV) as an antigen fraction in a multivalent 6-way vaccine containing modified-live virus and an inactivated Mannheimia haemolytica bacterin-toxoid was given as a single subcutaneous injection, and evaluated by an aerosol challenge by nebulization in young calves with virulent BRSV strain 21 d after vaccination. A total of 32 Holstein calves, seronegative to BRSV and 60 days-of-age at the time of vaccination, were used in the study. Calves were allocated to 2 treatment groups with 16 animals per group, and received either a single dose of a modified-live bovine herpes virus-1, bovine viral diarrhea virus, parainfluenza 3 virus, bovine respiratory syncytial virus vaccine + M. haemolytica bacterin-toxoid, or corresponding placebo formulation without targeted BRSV antigen. Administration of the 6-way vaccine containing BRSV fraction induced significantly higher virus-neutralizing antibody (p=0.0003) and anti-BRSV IgG titers (p=0.0006) in vaccinated animals compared to the placebo group. Consequently, BRSV-vaccinated calves had significantly (p&amp;lt;0.0001) higher arterial partial pressures of oxygen (PaO2), significantly (p&amp;lt;0.0001) lower percentage of lung lesions, and significantly reduced mortality rate (p&amp;lt;0.0001) than did placebo vaccinated calves subsequent to BRSV challenge. Furthermore, there was a 61.2% reduction in virus shedding and duration of shedding (p&amp;lt;0.0001), indicating strong vaccine efficacy.</dc:description>
	<dc:publisher xml:lang="en">American Association of Bovine Practitioners</dc:publisher>
	<dc:date>2021-02-01</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://bovine-ojs-tamu.tdl.org/bovine/article/view/8195</dc:identifier>
	<dc:identifier>10.21423/bovine-vol55no1p13-19</dc:identifier>
	<dc:source xml:lang="en">The Bovine Practitioner; Vol. 55, No. 1 (2021); 13-19</dc:source>
	<dc:source>0524-1685</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://bovine-ojs-tamu.tdl.org/bovine/article/view/8195/8134</dc:relation>
	<dc:rights xml:lang="en">Copyright (c) 2021 American Association of Bovine Practitioners</dc:rights>
</oai_dc:dc>
			</metadata>
		</record>
		
